2,992
回編集
差分
ナビゲーションに移動
検索に移動
→WHO Guideline 2019
*[https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/treatment/monitoring-toxicity-of-antiretrovirals WHO reference page is here]
====Adults and adolescents===
<div style="float:left; padding-right:1em;">
{|class="wikitable" style="width:400px; text-align:center"
|+Adults and adolescents1st line
|-
!colspan="3"|NRTI
<div style="float:left; padding-right:1em;">
{|class="wikitable" style="width:400px; text-align:center"
|+ChildrenAlternative 1st line
|-
!colspan="3"|NRTI
<div style="float:left; padding-right:1em;">
{|class="wikitable" style="width:400px; text-align:center"
|+Special circumstances|-!colspan="3"|NRTI|-|colspan="3"|Tenofovir<br>TDF|-|colspan="3"|Tenofovir alafenamide fumarate<br>TAF|-|colspan="3"|Lamivudine<br>3TC|-|colspan="3"|Zidovudine<br>AZT|-|colspan="3"|Abacavir<br>ABC|-!style="width:33.3%"|NNRTI!style="width:33.3%"|INI!style="width:33.3%"|PI|-|Efavirenz<br>EFV|Dolutegravir<br>DTG|Lopinavir-Ritonavir<br>LPV-r|-|Nevirapine<br>NVP|Raltegravir<br>RAL|Atazanavir<br>ATV-r|}</div> <div style="clear:both;"></div> ====Children===<div style="float:left; padding-right:1em;">{|class="wikitable" style="width:400px; text-align:center"|+1st line|-!colspan="3"|NRTI|-|colspan="3"|Tenofovir<br>TDF|-|colspan="3"|Tenofovir alafenamide fumarate<br>TAF|-|colspan="3"|Lamivudine<br>3TC|-|colspan="3"|Zidovudine<br>AZT|-|colspan="3"|Abacavir<br>ABC|-!style="width:33.3%"|NNRTI!style="width:33.3%"|INI!style="width:33.3%"|PI|-|Efavirenz<br>EFV|Dolutegravir<br>DTG|Lopinavir-Ritonavir<br>LPV-r|-|Nevirapine<br>NVP|Raltegravir<br>RAL|Atazanavir<br>ATV-r|}</div> <div style="float:left; padding-right:1em;">{|class="wikitable" style="width:400px; text-align:center"|+Alternative 1st line|-!colspan="3"|NRTI|-|colspan="3"|Tenofovir<br>TDF|-|colspan="3"|Tenofovir alafenamide fumarate<br>TAF|-|colspan="3"|Lamivudine<br>3TC|-|colspan="3"|Zidovudine<br>AZT|-|colspan="3"|Abacavir<br>ABC|-!style="width:33.3%"|NNRTI!style="width:33.3%"|INI!style="width:33.3%"|PI|-|Efavirenz<br>EFV|Dolutegravir<br>DTG|Lopinavir-Ritonavir<br>LPV-r|-|Nevirapine<br>NVP|Raltegravir<br>RAL|Atazanavir<br>ATV-r|}</div> <div style="float:left; padding-right:1em;">{|class="wikitable" style="width:400px; text-align:center"|+Special circumstances|-!colspan="3"|NRTI|-|colspan="3"|Tenofovir<br>TDF|-|colspan="3"|Tenofovir alafenamide fumarate<br>TAF|-|colspan="3"|Lamivudine<br>3TC|-|colspan="3"|Zidovudine<br>AZT|-|colspan="3"|Abacavir<br>ABC|-!style="width:33.3%"|NNRTI!style="width:33.3%"|INI!style="width:33.3%"|PI|-|Efavirenz<br>EFV|Dolutegravir<br>DTG|Lopinavir-Ritonavir<br>LPV-r|-|Nevirapine<br>NVP|Raltegravir<br>RAL|Atazanavir<br>ATV-r|}</div> <div style="clear:both;"></div> ====Neonates===<div style="float:left; padding-right:1em;">{|class="wikitable" style="width:400px; text-align:center"|+1st line|-!colspan="3"|NRTI|-|colspan="3"|Tenofovir<br>TDF|-|colspan="3"|Tenofovir alafenamide fumarate<br>TAF|-|colspan="3"|Lamivudine<br>3TC|-|colspan="3"|Zidovudine<br>AZT|-|colspan="3"|Abacavir<br>ABC|-!style="width:33.3%"|NNRTI!style="width:33.3%"|INI!style="width:33.3%"|PI|-|Efavirenz<br>EFV|Dolutegravir<br>DTG|Lopinavir-Ritonavir<br>LPV-r|-|Nevirapine<br>NVP|Raltegravir<br>RAL|Atazanavir<br>ATV-r|}</div> <div style="float:left; padding-right:1em;">{|class="wikitable" style="width:400px; text-align:center"|+Alternative 1st line|-!colspan="3"|NRTI|-|colspan="3"|Tenofovir<br>TDF|-|colspan="3"|Tenofovir alafenamide fumarate<br>TAF|-|colspan="3"|Lamivudine<br>3TC|-|colspan="3"|Zidovudine<br>AZT|-|colspan="3"|Abacavir<br>ABC|-!style="width:33.3%"|NNRTI!style="width:33.3%"|INI!style="width:33.3%"|PI|-|Efavirenz<br>EFV|Dolutegravir<br>DTG|Lopinavir-Ritonavir<br>LPV-r|-|Nevirapine<br>NVP|Raltegravir<br>RAL|Atazanavir<br>ATV-r|}</div> <div style="float:left; padding-right:1em;">{|class="wikitable" style="width:400px; text-align:center"|+Special circumstances
|-
!colspan="3"|NRTI
